Insulinoma

Adenoma of beta cells, leading to excessive insulin production and:

• Neuroglycopaenia
• Hypoglycaemia
  Relieved with glucose.

Epidemiology and Risk Factors

Risk factors:

• F>M

Pathophysiology

Aetiology

Clinical Manifestations

Diagnostic Approach and DDx

Investigations

Management

Medical

Surgical

Anaesthetic Considerations

• D
  • Glucose management complex
    • Continuous 5-10% glucose whilst fasting
      Often require prolonged (e.g. 72 hours) fast.
    • BSL Q30 min until on tumour
    • BSL Q15 min on tumour
    • May need insulin post-operatively

Marginal and Ineffective Therapies

Complications

Prognosis

Key Studies

---

References